Can You Stop Mounjaro for 2 Weeks — and What Happens When You Do?

What happens in your body when you miss two injections

Tirzepatide's half-life sits at roughly five days. That sounds reassuring until you do the arithmetic: after two weekly doses are missed, your plasma concentration has dropped to a fraction of its therapeutic level. The dual GIP and GLP-1 receptor signalling that slows gastric emptying and dampens appetite weakens in step. For many people this becomes noticeable faster than they expect, hunger returns more sharply, food feels less filling, and blood-sugar regulation (for those using Mounjaro for type 2 diabetes alongside weight management) becomes less stable.

The NHS patient information for tirzepatide confirms this pattern and is frank about what a missed dose means practically: if more than four days have passed since a dose was due, that injection should be skipped entirely and the normal weekly schedule resumed. Two consecutive missed doses therefore puts you firmly outside the medicine's protective window. Understanding how Mounjaro works in the first place helps frame why the break matters as much as it does.

One thing worth knowing: the body does not retain a pharmacological 'memory' of having been on treatment. You restart from where the medicine left off, not from where your weight-loss progress left off.

What clinical evidence says about stopping tirzepatide and weight regain

The SURMOUNT programme provides the most relevant data here. Post-trial follow-up from SURMOUNT-1, published in the New England Journal of Medicine, documented that participants who discontinued tirzepatide regained a substantial portion of the weight lost during the treatment period. The reversal is not immediate, but it begins promptly, and it is steepest in the weeks immediately after stopping, when appetite returns to pre-treatment levels while dietary habits have not yet adjusted.

For a two-week pause specifically, the picture is nuanced. Two weeks is long enough to feel the return of appetite and potentially to see the scale move upward slightly, but it is not long enough to undo months of progress entirely. The concern is less about two weeks in isolation and more about the pattern it can set: a planned fortnight's break can drift into four weeks, and at that point the research on what happens when Mounjaro's effects reverse becomes more directly relevant.

NICE's appraisal of tirzepatide (TA1026) frames it as a long-term intervention; the guidance published by NICE specifically considers ongoing use as the expected model, not a fixed course followed by discontinuation.

Surgery, travel and other legitimate reasons to pause, what to tell your prescriber

There are genuine medical reasons a prescriber might advise a short break. Surgery is the clearest example: NHS England guidance recommends telling your anaesthetist and surgical team that you take a GLP-1 medicine, and some teams ask for a pause beforehand because slowed gastric emptying can affect anaesthetic risk. If an operation is coming up, raise it directly with your prescriber rather than stopping unilaterally.

Travel is a different matter. Mounjaro requires refrigeration at 2–8°C, and keeping a KwikPen cold across a long-haul journey takes planning. The answer to a travel question is rarely 'stop the medicine' (it is usually 'plan the storage') but if you're facing a situation where cold chain simply cannot be maintained, your prescriber needs to know. The Mounjaro patient information leaflet, available via the electronic Medicines Compendium, gives the precise room-temperature tolerance window; do not guess at it.

Supply interruptions are also a real-world issue. If your pen is delayed or unavailable, contact your prescriber promptly rather than waiting in silence. A one-week gap is addressed slightly differently to two; for shorter pauses you can read about stopping Mounjaro for one week and whether the restart logic changes.

Restarting after two weeks: dose, timing and what to discuss

This is where individual clinical judgement matters most, and it is the reason a prescriber is required rather than a general guide. The broad principle is that a two-week break is long enough that returning straight to the dose you were on (particularly a mid-to-high dose like 7.5mg or 10mg) may bring GI side effects that were no longer a problem when you were stable. Stepping back one dose level for a month before re-titrating is common practice, but common is not universal.

If you are considering restarting and thinking about whether it makes sense to continue at all, the question of stopping for two weeks and restarting covers the practical logistics in more detail, including what evidence of current weight to bring to that conversation. The broader context of how early weeks of treatment behave (particularly what the first two weeks on Mounjaro typically look like) is also useful background if you are returning to a lower dose.

Cost is a real factor for many people considering a break. If the question is partly financial, reading about Mounjaro pricing in the UK alongside what is included in a private prescription service may help. At nume, every repeat order is clinically re-reviewed before dispatch (including returns from a break) so the prescriber can advise on the right re-entry dose for you specifically. If you'd like that conversation, check your eligibility and our team will take it from there.